glp-1 agonists weight loss drugs market Receptor Agonist to Grow at 17.5% CAGR till 2035 GLP-1 Agonists Market Exclusive Research
Description
The increased pressure can damage the optic nerves and cause vision loss if untreated
By dampening inflammation and modulating microglial activity, GLP-1 RAs create a neuroprotective environment that supports neuronal survival [78]
The ease of administration and long-term management of diabetes and obesity with oral GLP-1 receptor agonist is driving their widespread adoption
Recent cardiovascular outcome trials involving GLP-1 receptor agonists, especially liraglutide and semaglutide, have shown a significant reduction in major adverse cardiovascular events (MACE) among patients with type 2 diabetes at high risk for cardiovascular disease (36)
[DOI] [PubMed] [Google Scholar] 115.Chen JJ, et al
